LENSAR Q1 2026 Earnings Call Summary

1Key Financial Results and Metrics

Total Revenue: $13.4 million, down 5% from $14.2 million in Q1 2025.

System Revenue: Approximately $800,000, significantly lower than $2.6 million in the prior year, attributed to reduced system placements.

Recurring Revenue: Increased by 9% to $12.6 million, representing 94% of total revenue.

Gross Margin: 48% of revenue, down from 50% year-over-year.

Operating Expenses: Totaled $4.1 million, a significant decrease from $12.9 million in Q1 2025, largely due to a $4.4 million credit from acquisition costs.

Net Income: $36.3 million or $1.56 per share, compared to a net loss of $27.3 million a year ago, influenced by noncash items.

Adjusted EBITDA: Negative $311,000, down from positive $165,000 in Q1 2025.

Cash Position: Ended the quarter with $13.5 million in cash and equivalents.

2Strategic Updates and Business Highlights

LENSAR has exited a merger-related holding pattern, allowing it to focus on independent growth and expansion.

The company placed 7 ALLY systems during the quarter, bringing the total installed base to approximately 205 systems, with 11 more in backlog.

Procedure volume increased to about 54,000, up from 52,000 in Q1 2025, with a U.S. market share of 23.4%.

Strong interest in ALLY was noted at industry events, with over 50 system demonstrations conducted.

The company is optimistic about rebuilding its international presence and expanding its installed base.

3Forward Guidance and Outlook

Management expects continued growth in recurring revenue as the installed base expands and utilization rates improve.

The next few quarters are anticipated to show steady progress in rebuilding momentum, particularly in system placements.

While specific guidance was not provided, there is optimism regarding a rebound in growth rates, especially looking towards 2027.

4Bad News, Challenges, or Points of Concern

The decline in system revenue reflects ongoing challenges in placement activity, particularly due to the prior merger uncertainty.

The international market has seen limited contributions over the past year, impacting overall growth.

Operating expenses are expected to rise as LENSAR rebuilds its workforce to support growth.

Competitive pressures remain, particularly from older systems like Alcon's LenSx, which may delay decision-making among potential customers.

5Notable Q&A Insights

Management confirmed that recent purchase orders from distributors indicate a positive trend in rebuilding relationships and sales.

There is a cautious approach to increasing operating expenses, with plans to rebuild the team judiciously.

The company emphasized the importance of the recurring revenue model, which is expected to support growth even during slower system placement periods.

There is confidence in the ability to convert users of older systems, with a focus on the efficiency and benefits of the ALLY system compared to competitors. Overall, LENSAR is positioned for recovery and growth following a challenging period, with a strong emphasis on enhancing its technology and expanding its market presence.